These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25569728)

  • 1. Right to health encompasses right to access essential generic medicines: challenging the 2008 Anti-Counterfeit Act in Kenya.
    Maleche A; Day E
    Health Hum Rights; 2014 Dec; 16(2):E96-E104. PubMed ID: 25569728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incorporating a right to health perspective into the resolution of patent law disputes.
    Oke EK
    Health Hum Rights; 2013 Dec; 15(2):97-109. PubMed ID: 24421172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. When falsified medicines enter the supply chain: description of an incident in Kenya and lessons learned for rapid response.
    Cohn J; von Schoen-Angerer T; Jambert E; Arreghini G; Childs M
    J Public Health Policy; 2013 Jan; 34(1):22-30. PubMed ID: 23172047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kenya says yes to generic ARVs but fails to win Global Fund cash.
    Njoroge J
    Bull World Health Organ; 2002; 80(7):608. PubMed ID: 12163933
    [No Abstract]   [Full Text] [Related]  

  • 5. Amendments to the Canadian Patent Act to address drug access: is help on the way?
    Penner MD; Narayanan P
    Food Drug Law J; 2005; 60(3):459-70. PubMed ID: 16304751
    [No Abstract]   [Full Text] [Related]  

  • 6. Law and pediatric HIV testing: realizing the right to health in Kenya.
    Verani AR; Orago AS; Kariuki CN; Muraguri N; Koros D; Marston B; De Cock KM
    J Int Assoc Provid AIDS Care; 2014; 13(4):379-83. PubMed ID: 25513037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generic drugs battle moves from South Africa to Kenya.
    Siringi S
    Lancet; 2001 May; 357(9268):1600. PubMed ID: 11377665
    [No Abstract]   [Full Text] [Related]  

  • 8. Emory law school conference tackles access to generic AIDS drugs.
    AIDS Policy Law; 2003 Apr; 18(8):4. PubMed ID: 12739488
    [No Abstract]   [Full Text] [Related]  

  • 9. Health rights litigation and access to medicines: priority classification of successful cases from Costa Rica's constitutional chamber of the Supreme Court.
    Norheim OF; Wilson BM
    Health Hum Rights; 2014 Dec; 16(2):E47-61. PubMed ID: 25569724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Africa, access, and patents: moving fast.
    James JS
    AIDS Treat News; 1999 Jul; (No 322):5-8. PubMed ID: 11366567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is access to essential medicines as part of the fulfilment of the right to health enforceable through the courts?
    Hogerzeil HV; Samson M; Casanovas JV; Rahmani-Ocora L
    Lancet; 2006 Jul; 368(9532):305-11. PubMed ID: 16860700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. International. Rights group: U.S. blocking access to generic AIDS drugs.
    AIDS Policy Law; 2004 Apr; 19(7):1, 4. PubMed ID: 15124593
    [No Abstract]   [Full Text] [Related]  

  • 13. Kenyan AIDS advocates launch legal fight for generic drugs.
    AIDS Policy Law; 2003 Jun; 18(11):2. PubMed ID: 12866464
    [No Abstract]   [Full Text] [Related]  

  • 14. Judicialisation of the right to health in Brazil.
    Biehl J; Petryna A; Gertner A; Amon JJ; Picon PD
    Lancet; 2009 Jun; 373(9682):2182-4. PubMed ID: 19560587
    [No Abstract]   [Full Text] [Related]  

  • 15. Viewpoint: Counterfeit medicines and substandard medicines: Different problems requiring different solutions.
    't Hoen E; Pascual F
    J Public Health Policy; 2015 Nov; 36(4):384-9. PubMed ID: 26178809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration.
    Hogerzeil HV; Liberman J; Wirtz VJ; Kishore SP; Selvaraj S; Kiddell-Monroe R; Mwangi-Powell FN; von Schoen-Angerer T;
    Lancet; 2013 Feb; 381(9867):680-9. PubMed ID: 23410612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fake drugs, what are we talking about? Counterfeit drugs, informal market, quality of pharmaceutical… Thought from an anthropological study led in Benin].
    Baxerres C
    Bull Soc Pathol Exot; 2014 May; 107(2):121-6. PubMed ID: 24639135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An exploration of compulsory licensing as an effective policy tool for antiretroviral drugs in India.
    Jain D; Darrow JJ
    Health Matrix Clevel; 2013; 23(2):425-57. PubMed ID: 24341078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Will they deliver treatment access?: WTO rules and Canada's law on generic medicine exports.
    Elliott R
    HIV AIDS Policy Law Rev; 2006 Dec; 11(2-3):13-6. PubMed ID: 17373059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulatory framework for access to safe, effective quality medicines.
    Rägo L; Sillo H; 't Hoen E; Zweygarth M
    Antivir Ther; 2014; 19 Suppl 3():69-77. PubMed ID: 25310085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.